Arrhythmias-Targeting Compound 1 is a compound extracted from patent WO 2001028992 A2. It is used in the research of arrhythmias.

335619-12-0

C22H32N4O2

384.52

Arrhythmias-Targeting Compound 1

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years